2Brooks JW, Hamilton-Easton AM, Christensen JP, et al. Requirement for CD40 ligand, CD4 + T cell, and B cells in an infectious mononucleosis-like syndrome.J Virol, 1999, 73(11) : 9650- 9654.
3Long SS, Pickering LK, Prober CG. Principles and practice of pediatric infectious diseases, 1th.United States. Churchill Livingstone, 1997 : 1185 - 1190.
4Maini MK, Gudgeon N, Wedderburn LR, et al. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.J Immunol, 2000,165(1) : 5729- 5737.
5Nikiforow S, Bottomly K, Miller G. CD4 + T cell effectors inhibit Epstein-Barr virus-induced B-cell'proliferation.J Virol, 2001, 75(4) : 3740- 3752.
6Callan MF, Fazon C, Yang H, et al. CD8 + T cell selection,function, and death in the primary immune response in vivo.J Clin Invest, 2000,106(10) : 1251- 1261.
7Silins SL, Sherritt MA, Silleri MA, et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbatins despite high level of systemic viral load. Blood, 2001, 98 :3739- 3744.
8Coppola MA, Flano E, Nguyen P, et al. Apparent MHC-independent stimulation of CD8 + T cell in vivo during latent murine gammaherpesvirus infection. J Immunol,1999, 163 : 1481- 1489.
9Khanna R, Burrows SR. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.Annu Rev Microbiol, 2000, 54 : 19- 48.
